AGREEMENT OPENS UP $1.3 BILLION MARKET FOR EMEFCY

AGREEMENT OPENS UP $1.3 BILLION MARKET FOR EMEFCY

EMEFCY (ASX: EMC) has signed a deployment and distribution partnership for its Membrane Aerated Biofilm Reactor (MABR) wastewater treatment technology with Beijing Sinorichen Environmental Protection Corporation.

The agreement opens up access to a market worth up to $1.3 billion for the Melbourne-based company, which manufactures its technology out of Israel.

The Chinese government has a five-year plan to build new rural wastewater treatment plants supporting a population of around 50 million people in the provinces in Beijing and to its north.

Sinorichen has an established wastewater treatment consulting business and it intends to deploy the MABR-based wastewater treatment systems to rural communities in the Beijing Province and throughout northern China.

The partnership starts with a demonstration project in Miyun district and when that meets required performance criteria, the parties will launch a multi-phase deployment roll out plan. First, Sinorichen will use the systems for up to seventy rural installations each worth between $50,000-$250,000. It will then market the technology throughout northern China.

Richard Irving, Executive Chairman of Emefcy says Miyun District is one of China's most progressive provinces and Sinorichen represents a Emefcy's "preferred profile of partnership in China", and will accelerate deployment in other provinces.

"Emefcy is investing substantial resources and starting to make important inroads in penetrating the rural wastewater treatment market in China," he says.

The MABR modules will initially be produced at Emefcy's manufacturing facility in Israel, but the company of seeking licence approvals to establish manufacturing facilities in Jiangsu Province and the first manufacturing line in China is expected to be in place by the second quarter of 2017.

The first Sinorichen installed MABR-based system is scheduled to be commissioned during the fourth quarter of 2016 and provisional certification is expected by the third quarter for 2017.

For all joint future contracts, Sinorichen will purchase MABR modules from Emefcy, will integrate them under Emefcy's technical guidance into a complete treatment system and provide ongoing plant maintenance and related services.

This is Emefcy's second strategic partnership announcement in two months following its announcement on 15 August of a distribution agreement with Wuxi Municipal Design Institute.

Emefcy shares are trading up 11.59 per cent on the ASX this morning at $1.155 per share.

 

Get our daily business news

Sign up to our free email news updates.

 
Whitefox Recruitment founder Luke Hemmings making strides as a careers leader
Partner Content
After relocating his Canberra-founded company Whitefox Recruitment to the Gold Coast la...
Whitefox Recruitment
Advertisement

Related Stories

ASIC secures its first court win for greenwashing against US giant Vanguard

ASIC secures its first court win for greenwashing against US giant Vanguard

The Australian corporate watchdog has caught out one of the world&r...

Medicinal cannabis group Althea shaves $1.5m from its cost base through staff cutbacks

Medicinal cannabis group Althea shaves $1.5m from its cost base through staff cutbacks

Australian-founded medicinal cannabis company Althea Group (ASX: AG...

Charter Hall snares 15pc stake in Hotel Property Investments for $97m from 360 Capital

Charter Hall snares 15pc stake in Hotel Property Investments for $97m from 360 Capital

Listed funds manager 360 Capital Group (ASX: TGP) has offloaded its...

Lendlease gains approval for $1.7b transformation of Queen Victoria Market precinct

Lendlease gains approval for $1.7b transformation of Queen Victoria Market precinct

Australian development giant Lendlease Group (ASX: LLC) has been gr...